Nora Henrikson (she/her) is an associate investigator at Kaiser Permanente Washington Health Research Institute. She leads a research portfolio focused on interventions to improve cancer care delivery, health equity, and patient outcomes.
Her current research explores methods for improving risk notification and cascading genetic testing for family members of people with hereditary cancers as well as interventions to mitigate cancer-related financial hardship. Dr. Henrikson also leads systematic evidence reviews on cancer screening and behavioral counseling with the Kaiser Permanente Evidence-based Practice Center.
Dr. Henrikson holds affiliate faculty appointments at the University of Washington School of Public Health, Department of Health Systems and Population Health and Institute for Public Health Genetics; and the Bernard J. Tyson Kaiser Permanente School of Medicine. She has a PhD from the University of Washington School of Public Health Institute for Public Health Genetics, an MPH from the University of North Carolina at Chapel Hill, and a BA (sociology) from Lehigh University.
Social/behavioral quantitative and qualitative research; intervention design; systematic review and evidence synthesis; epidemiology; patient-provider communication
Genetic testing for cancer risk, cancer-related financial hardship
Social, ethical, and policy implications of genomics and precision health
Henrikson NB, Davison BJ, Berry DL. Measuring decisional control preferences in men newly diagnosed with prostate cancer. J Psychosoc Oncol. 2011;29(6):606-18. PubMed
Grossman D, Fishman P, Beck A, Reid R, Ritzwoller D, Martin D, Henrikson N, Hubbard R, Scrol A. Quasi-experimental evaluation of a value-based health plan design among healthcare employees. Clin Med Res. 2011;9(3-4):173-4.
Standaert CJ, Friedly J, Erwin MW, Lee MJ, Rechtine G, Henrikson NB, Norvell DC. Comparative effectiveness of exercise, acupuncture, and spinal manipulation for low back pain. Spine. 2011;36(21 Suppl):S120-30. PubMed
Henrikson NB, Ellis WJ, Berry DL. "It's not like I can change my mind later": reversibility and decision timing in prostate cancer treatment decision-making. Patient Educ Couns. Nov;77(2):302-7. Epub 2009 Apr 21.
Henrikson NB, Bowen D, Burke W. Does genomic risk information motivate people to change their behavior? Genome Med. 2009 Apr 2;1(4):37.
James RD, Yu JH, Henrikson NB, Bowen DJ, Fullerton SM. Strategies and stakeholders: minority recruitment in cancer genetics research. Community Genet. 2008;11:241-49.
Henrikson NB, Harris JN, Bowen D. Predictors of recruitment method to a cancer genetics registry. Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1387-92.
Henrikson NB, Burke W, Veenstra DL. Ancillary risk information and pharmacogenetic tests: social and policy implications. Pharmacogenomics J. 2008 Apr;8(2):85-9. PubMed
Battuello K, Henrikson NB. Genetics and public health: past, present, and future In: Battuello K, Kuslzer P, O’Connor S, editors. Genetic technologies and the law: cases and materials. Carolina Academic Press; 2006.
Battuello K, Henrikson NB. Access to and disclosure of genetic information: rights, duties and liabilities. In: Battuello K, Kuslzer P, O’Connor S, editors. Genetic technologies and the law: cases and materials. Carolina Academic Press; 2006.
The HCSRN conference is a venue for collaborative work to improve health and health care.
Dr. Henrikson’s Annals of Internal Medicine study describes 3 kinds of cost concerns that can affect cancer care.
Nora Henrikson discusses her latest research published in the Annals of Internal Medicine in May 2019. (Vimeo, 3:50)
Leah Tuzzio, MPH, and colleagues describe an underutilized role that can help primary care become truly patient-centered.